Skip to content
ReportSmart UK

The Zimbabwean Government Rejects ‘Unbalanced’ American Health Aid Agreement Due to Information Apprehensions

Health funding image
The offered US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has declined a major US health deal valued at 367 million US dollars (£272m) over five years because of Washington's demand for confidential information.

This move came to light after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".

A government representative has since explained that the United States was requesting genetic material for research and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.

"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for further talks to reach a agreement suitable to both sides so the nation's vital HIV treatment initiative can continue.

Broader Background

This rejection follows a comparable case in Kenya, where a high court halted a related deal with the US after concerns were raised about the security of Kenyans' health data.

Since resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and accountability.

As per statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," Mangwana explained.

"Put simply, our country would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our population if a future disease outbreak emerge."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems previously established via the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This system is designed to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."

These objections regarding the US deal "are not meant as hostility towards the US," he added.

"We welcome further discussions with our American counterparts on how subsequent co-operation could be designed in a manner that respects the independence and dignity of each country."

Health Experts Reaction

Medical experts expressed it acknowledged the official position, but urged that talks need to persist since much of the nation's HIV programmes relied on foreign aid.

"Where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the ongoing tensions between receiving vital international aid and protecting a country's data in an increasingly interconnected world.

The writer

Martha Fuller

Data scientist and business intelligence consultant with over 8 years of experience in transforming raw data into actionable insights for UK enterprises.

ReportSmart UK

Type to search articles.